ArticleArchives of virology2026
Epidemiological and evolutionary analysis of porcine circovirus type 2 within pig populations in central China during 2021-2024.
Article in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Porcine circovirus type 2 (PCV2) is a major swine pathogen associated with immunosuppression and diverse clinical syndromes, posing a persistent threat to the pig industry. Updated epidemiological and molecular data are essential for effective disease control. In this study, a total of 14,436 samples collected from 18 cities in Henan Province, central China, between 2021 and 2024 were examined for PCV2 using real-time PCR. Prevalence was analyzed according to year, season, region, and farm source, and farm-level infection rates were also assessed. In addition, 30 PCV2 whole genomes were sequenced and genetically characterized. Overall, PCV2 was detected in 22.32% (3,222/14,436) of samples and was present in all surveyed cities, with prevalence ranging from 6.47% to 49.93%. Temporal analysis revealed a peak in 2022 and a consistently lower prevalence in the third quarter. Significant geographic heterogeneity was observed across regions. PCV2 prevalence was highest in samples from diseased pigs, followed by slaughterhouses, whereas commercial and breeding farms showed lower detection rates. Multivariable logistic regression confirmed that region, season, and farm type were independently associated with PCV2 positivity. Phylogenetic analysis based on ORF2 sequences showed that PCV2d was the predominant genotype, alongside PCV2a and PCV2b, and sequence comparison revealed notable divergence from commonly used vaccine strains. These findings demonstrate that PCV2 remains widely circulating in central China, with distinct epidemiological patterns and ongoing genetic evolution, underscoring the need for continuous surveillance and optimized vaccination strategies.
Indexed as
Identifiers
41888445What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.